ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,550, issued on April 21, was assigned to CRT Pioneer Fund LP (Great Britain).
"Methods for synthesis of CHK1 inhibitors" was invented by Michael Schwaebe (San Mateo, Calif.), Thorsten Rosner (San Mateo, Calif.), Dalian Zhao (San Mateo, Calif.), Ross Miller (San Mateo, Calif.), Rich Dulina (San Mateo, Calif.), Michael Humora (San Mateo, Calif.) and Stephen E. Gottschling (San Mateo, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates to processes, compounds, compositions, and methods useful for coupling reactions. Also, the present disclosure provides for novel intermediates, compositions of matter, and processes rel...